AIMS: To evaluate @entity86 after Greenlight    photovaporisation of the prostate ( @entity12468 ), through a dedicated questionnaire. METHODS: A retrospective study has been conducted between 2008 and 2014. The questionnaire had 5 sections about @entity158 while voiding, @entity811 , urgency, @entity322 and urinary stream, and was filled at one-month postoperative. The main outcome criterion was @entity158 while voiding. Descriptive statistical analyses were done to identify predictive factors for @entity158 while voiding. RESULTS: Out of 169 @entity1 , 22% had no @entity158 while voiding, 37% had moderate @entity158 , 30% acceptable @entity158 and 11% intense @entity158 . @entity1 with @entity158 were significantly older, (P=0.012), had more urgency (P=0.01) and more often @entity811 (P=0.0001). Only 7% of @entity1 had no symptoms of urgency, and urgency was painful or bothering in 57% of cases. @entity811 was frequent, with clots in 21% of cases. Ninety three percent felt improvement of urinary stream. CONCLUSIONS: Systematic evaluation of symptoms through a dedicated questionnaire one month after @entity12468 has shown that 41% of @entity1 felt @entity158 while voiding, 57% had urgency and 39% significant @entity811 . These results should encourage a more accurate @entity1 information and further studies to better understand postoperative healing after @entity12468 . LEVEL OF EVIDENCE: 5.

[Evaluation of XXXX after Greenlight    photovaporization of the prostate through a dedicated questionnaire].

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity322 :: ('MESH:D014549', 'Disease') :: ['incontinence'] @entity12468 :: ('CHEBI:53245', 'Chemical') :: ['PVP'] @entity86 :: ('MESH:D019106', 'Disease') :: ['postoperative symptoms'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain'] @entity811 :: ('MESH:D006417', 'Disease') :: ['hematuria', 'Hematuria']
@entity86 :: (MESH:D019106,Disease) :: ['postoperative symptoms']
